You are currently viewing Arteriotomy Closure Devices Market 2026: Market Size, Growth Drivers And Emerging Opportunities
Arteriotomy Closure Devices Market Analysis

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Arteriotomy Closure Devices Market Forecast: Value Set To Climb From $1.84 Billion To $2.38 Billion#_x000D_

The arteriotomy closure devices market size has shown strong expansion over recent years. This market is expected to increase from $1.72 billion in 2025 to $1.84 billion in 2026, registering a compound annual growth rate (CAGR) of 6.9%. The rise observed in the historic period can be linked to an increasing volume of catheter-based interventions, a broader uptake of minimally invasive angiography procedures, the growing prevalence of cardiovascular disease, enhanced clinical acceptance of closure devices, and the expansion of interventional cardiology services._x000D_

_x000D_

The arteriotomy closure devices market size is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $2.38 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. This projected increase during the forecast period is largely driven by factors such as the rising demand for advanced vascular closure methods, a heightened emphasis on minimizing complications from procedures, the proliferation of outpatient vascular interventions, increasing investments in bioresorbable substances, and the wider acceptance of cutting-edge closure technologies. Furthermore, key developments anticipated in this period encompass the growing embrace of suture-based closure devices, a developing preference for radial access closure options, the expanded application of bioabsorbable hemostatic materials, the broadening scope of minimally invasive vascular procedures, and a greater concentration on expediting patient recovery._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=26687498&type=smp&name=Arteriotomy%20Closure%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR_x000D_

_x000D_

#Arteriotomy Closure Devices Market Growth Catalysts And Demand Drivers#_x000D_

The rising incidence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the arteriotomy closure devices market in the coming years. CVDs are a range of conditions that affect the heart and blood vessels. This increase in CVD prevalence is largely attributed to growing risk factors such as unhealthy diets, lack of physical activity, and obesity, alongside an aging population. Arteriotomy closure devices play a vital role in cardiovascular treatments by providing quick and secure sealing of arterial puncture sites, which helps reduce complications and improve patient recovery after procedures like angioplasties and catheterizations. For instance, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that in the UK, approximately 7.6 million individuals are currently affected by heart and circulatory diseases, comprising 4 million men and 3.6 million women. Projections suggest this number could increase by 1 million by 2030, and by 2040, it may rise to 2 million more than the current figures. Therefore, the growing prevalence of cardiovascular diseases (CVDs) is fueling the demand in the arteriotomy closure devices market._x000D_

_x000D_

#Arteriotomy Closure Devices Market Segmentation And Category Overview#_x000D_

The arteriotomy closure devices market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Active Closure Devices, Passive Closure Devices_x000D_

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures_x000D_

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices _x000D_

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs _x000D_

_x000D_

_x000D_

#Arteriotomy Closure Devices Market Trends Shaping Long-Term Demand#_x000D_

Companies operating within the arteriotomy closure devices market are focusing on product innovation to boost procedural efficiency, enhance patient outcomes, and address the increasing need for minimally invasive vascular access solutions. A mid-bore venous closure device functions as a medical instrument engineered to seal venous access points formed by mid-sized catheters or sheaths, thereby facilitating hemostasis and supporting patient recuperation following interventional procedures. As an illustration, in June 2024, Haemonetics Corp, a US-based healthcare firm, broadened its VASCADE portfolio by introducing the VASCADE MVP XL mid-bore venous closure device. This particular device, designed for larger sheaths (10-12F, up to 15F outer diameter) employed in procedures such as cryoablation, contains 58% more collagen and features an expanded collapsible disc to ensure quick hemostasis. This development, which augments Haemonetics’ current selection of small- and mid-bore vascular closure offerings, highlights the company’s leading position in sophisticated closure technologies._x000D_

_x000D_

#Arteriotomy Closure Devices Market Leading Companies And Competitive Benchmarking#_x000D_

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical _x000D_

_x000D_

#View The Full Arteriotomy Closure Devices Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR_x000D_

_x000D_

#Arteriotomy Closure Devices Market Top Region By Revenue And Market Share#_x000D_

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model